MyAverix Finance
SW · Healthcare
Basilea Pharmaceutica AG (BSLN)
Biotechnology
Basilea Pharmaceutica AG (BSLN) is listed on SW in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BSLN
Basilea Pharmaceutica AG (BSLN) — FAQ
What is BSLN's P/E ratio?
The price-to-earnings (P/E) ratio for Basilea Pharmaceutica AG (BSLN) is 18.00 (data as of 2026-03-22).
Does Basilea Pharmaceutica AG pay a dividend?
Dividend yield is not available in the current snapshot for Basilea Pharmaceutica AG (BSLN). Check the MyAverix Finance app for the latest dividend data.
What sector is Basilea Pharmaceutica AG in?
Basilea Pharmaceutica AG (BSLN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is BSLN listed on?
BSLN is listed on SW.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.